Skip to main content
. 2021 Mar 11;14:1756286421999017. doi: 10.1177/1756286421999017

Table 5.

Outcome according to stroke aetiology in propensity-matched analysis (matched according to demographic data and baseline characteristics).

Cardioembolic group
n = 118
Large-artery atherosclerosis group*
n = 118
p-value Odds ratio (95% CI) p-value shift analysis
mRS at 3 months 0.580
 0–1 29 (24.6%) 24 (20.3%) 0.436 1.28 (0.69–2.36)
 0–2 63 (53.4%) 57 (48.3%) 0.435 1.23 (0.74–2.04)
 0–5 (survival) 94 (79.7%) 102 (86.4%) 0.168 0.61 (0.31–1.23)
 Median, range 2, 0–6 3, 0–6 0.362
NIHSS score at discharge from acute care
 Median change, range −7, −20 to 34 −6, −25 to 37 0.640
 Median, range 4, 0–42 7, 0–42 0.076
Final in-hospital infarct volume 0.286 0.519
 <30 ml 56 (48.7%) 49 (41.5%)
 30–90 ml 40 (34.8%) 53 (44.9%)
 >90 ml 19 (16.5%) 16 (13.6%)
Successful reperfusion (mTICI 2b/3) 97 (82.2%) 88 (74.6%) 0.156 1.58 (0.84–2.95) 0.418
Updated Charlson Comorbidity Index 0.899
 Median, range 2, 0–16 2, 0–10 0.907
 Subitem heart failure 31 (26.3%) 21 (17.8%) 0.118 1.65 (0.88–3.08)
Symptomatic intracranial haemorrhage 3 (2.6%) 5 (4.2%) 0.491 0.60 (0.14–2.57) NA

Values are presented as number (%). Percentages indicate available data. Missing data were considered as missing, as they were incidentally missing.

*

Denominator.

Values compare both groups.

Shift over the whole spectrum of the score.

CI, confidence interval; mRS, modified Rankin scale; mTICI, modified thrombolysis in cerebral infarction; NIHSS, National Institutes of Health Stroke Scale.